LAROTRECTINIB

CHEBI:CHEBI_746905

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

active_ingredient_strength
1 kg/kg
nui
N0000193859
pharm_class_epc
Kinase Inhibitor [EPC]
pharm_class
Tropomyosin Receptor Kinases Inhibitors [MoA]
pharm_class_moa
Tropomyosin Receptor Kinases Inhibitors [MoA]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rxcui
2105657
generic_name
Larotrectinib Sulfate Micronized
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
route
OROPHARYNGEAL
dosage_form
SOLUTION, CONCENTRATE
marketing_start_date
20221206
package_marketing_start_date
08-JUN-22
active_ingredient_name
LAROTRECTINIB SULFATE
brand_name
VITRAKVI
brand_name_base
VITRAKVI
product_ndc
63069-392
application_number
NDA211710
labeler_name
W. R. Grace & Co.-Conn.
manufacturer_name
Bayer HealthCare Pharmaceuticals Inc.
spl_id
c5cd1041-e42d-42a4-8cca-06a63f86b217
package_ndc
63069-392-01
package_description
100 mL in 1 BOTTLE (63069-392-01)
unii
PF9462I9HX
spl_set_id
0c8ca614-58b2-4aa4-83d3-0387a8f782fd